ADS-8801

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameADS-8801

Drug Alias NameADS-8801

ClassificationSmall molecules

Mechanisms of ActionMatrix protein 2 inhibitors

TargetsMatrix protein 2

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdamas Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdamas Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A

Related LinksN/A